Literature DB >> 3155642

B- and T-lymphocytes in Hodgkin's disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies.

M Forni, F M Hofman, J W Parker, R J Lukes, C R Taylor.   

Abstract

Immunohistologic techniques utilizing monoclonal antibodies have made possible the identification of leukocytes by their phenotypic characteristics rather than by morphologic features alone. A panel of antibodies for T-lymphocyte, B-lymphocyte, and monocyte/histiocyte markers has been applied to frozen sections of nodular sclerosing and mixed cellularity Hodgkin's disease to identify more precisely the various cell types present in tissues involved in Hodgkin's disease. The majority of lymphocytes expressed detectable T-cell phenotypic markers, with a predominance of the "helper" phenotype (Leu 3/OKT4) in most cases. Lymphocytes reacting with anti-B-cell antibodies were also demonstrated; their distribution is described here and has not previously been reported. The anti-B- and anti-T-cell antibodies used in this study failed to give positive reactivity with Reed-Sternberg cells. However, one of the anti-monocyte antibodies (Leu-M1) reacted with diagnostic Reed-Sternberg cells in some cases. The patterns of staining observed varied widely within the two histologic types of Hodgkin's disease, leading to a conclusion that this disease may be more heterogeneous than is currently suspected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155642     DOI: 10.1002/1097-0142(19850215)55:4<728::aid-cncr2820550409>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.

Authors:  J A Strauchen; A Dimitriu-Bona
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

2.  Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.

Authors:  M E Kadin; L Muramoto; J Said
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.

Authors:  A J Norton; P G Isaacson
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

4.  Discordant lymphoma: a case report.

Authors:  J Coyne; W F Kealy; J Hogan; C Murphy
Journal:  Ir J Med Sci       Date:  1987-03       Impact factor: 1.568

5.  Reed-Sternberg cells, lymphocytes, and interdigitating reticulum cell rosettes in Hodgkin's disease.

Authors:  G van Parys; J Van den Oord; C de Wolf-Peeters; R de Vos; V J Desmet
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

Review 6.  Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature.

Authors:  P A Hall; A J D'Ardenne
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

7.  Morphological and immunohistochemical studies of Hodgkin's disease in the spleen.

Authors:  M Takeshita; S Falk; J Schwetje; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.

Authors:  L Bergmann; P S Mitrou; M Demmer-Dieckmann; F T Ruhmann; E Weidmann
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Hodgkin lymphoma: flow me?

Authors:  Michael W Beaty; Kim R Geisinger
Journal:  Cytojournal       Date:  2005-09-08       Impact factor: 2.091

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.